Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Edwards Lifesciences CorpEW · Entity 3026 | Director | May 08, 2026 | May 09, 2026 |
| JOHNSON & JOHNSONJNJ · Entity 2722 | Director · VP, Strategy & Growth · Member, Executive Committee | September 30, 2009 | October 02, 2009 |
| RTI SURGICAL, INC.RTIX · Entity 159205 | Director | March 08, 2019 | March 11, 2019 |
| Roka BioScience, Inc.ROKA · Entity 172682 | Director | June 28, 2017 | June 30, 2017 |
| SURGALIGN HOLDINGS, INC.SRGA · Entity 109633 | Director | August 15, 2022 | August 17, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Edwards Lifesciences Corp
Report date May 08, 2026 · Filed May 09, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 84,423 |
Reported balance
After 2026-05-08 transaction · row 1
1 source rowRow 1 · 2026-05-08 · Grant · Acquired 5,127 · Balance 84,423 F1: These restricted stock units were granted on May 8, 2026 under the Edwards Lifesciences Corporation 2020 Nonemployee Directors Stock Incentive Program. They are scheduled to become 100% vested after the earlier of one year from the grant date or the Issuer's next annual meeting of stockholders. |
Filing footnotes · ownership attribution and instrument terms
F1: These restricted stock units were granted on May 8, 2026 under the Edwards Lifesciences Corporation 2020 Nonemployee Directors Stock Incentive Program. They are scheduled to become 100% vested after the earlier of one year from the grant date or the Issuer's next annual meeting of stockholders.
JOHNSON & JOHNSON
Report date September 30, 2009 · Filed October 02, 2009
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| CommonSEC Table I · non-derivative | Direct | 57,353 |
Ending reported balance
After 2009-08-25 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2008-08-19 · Gift · Disposed 350 · Balance 57,703 F1: Gift Row 2 · 2009-08-25 · Gift · Disposed 350 · Balance 57,353 F1: Gift |
| CommonSEC Table I · non-derivative | IndirectJohnson & Johnson Stock Fund under the 401(k) Savings Plan | 8,784 |
Reported balance
After 2009-09-30 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2009-09-30 · Other · Acquired 76 · Balance 8,784 F2: Shares acquired in the Johnson & Johnson Stock Fund under Johnson & Johnson's 401(k) Savings Plan as of Plan's most recent reporting date (09/30/2009). |
| CommonSEC Table I · non-derivative | IndirectAs custodian for Son under UTMA | 4,525 |
Reported balance
After 2009-08-19 transaction · row 5
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 5 · 2009-08-19 · Gift · Acquired 350 · Balance 4,525 F1: Gift F4: The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. |
| Phantom Stock UnitsSEC Table II · derivative / convertible security | Direct | 6,886 |
Reported balance
After 2009-09-30 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2009-09-30 · Grant · Acquired 54 · Balance 6,886 F5: The Phantom Stock converts into common stock on a one-for-one basis. F6: Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan on September 30, 2009 at $61.15 per share are to be settled in cash upon the Reporting Person's Retirement (with each Phantom Stock Unit representing the fair market value of one share of Common Stock on the settlement date). Alternatively, the cash value represented by the Phantom Stock Units may be transferred by the Reporting Person into an alternative investment account under the Plan at any time. |
| CommonSEC Table I · non-derivative | IndirectESOP under the 401(k) Savings Plan | 1,292 |
Reported balance
Holding disclosure · report date 2009-09-30 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 1,292 F3: Shares held by ESOP under Johnson & Johnson's 401(k) Savings Plan as of Plan's most recent reporting date (09/30/2009). |
Filing footnotes · ownership attribution and instrument terms
F1: Gift
F2: Shares acquired in the Johnson & Johnson Stock Fund under Johnson & Johnson's 401(k) Savings Plan as of Plan's most recent reporting date (09/30/2009).
F3: Shares held by ESOP under Johnson & Johnson's 401(k) Savings Plan as of Plan's most recent reporting date (09/30/2009).
F4: The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
F5: The Phantom Stock converts into common stock on a one-for-one basis.
F6: Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan on September 30, 2009 at $61.15 per share are to be settled in cash upon the Reporting Person's Retirement (with each Phantom Stock Unit representing the fair market value of one share of Common Stock on the settlement date). Alternatively, the cash value represented by the Phantom Stock Units may be transferred by the Reporting Person into an alternative investment account under the Plan at any time.
RTI SURGICAL, INC.
Report date March 08, 2019 · Filed March 11, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2019-03-08 transaction · row 1
1 source rowRow 1 · 2019-03-08 · Disposition to issuer · Disposed 86,723 · Balance 0 F1: On March 8, 2019, pursuant to the Master Transaction Agreement, by and among the Issuer, RTI Surgical, Inc., a Delaware corporation ("Old RTI"), PS Spine Holdco, LLC, a Delaware limited liability company (the "Member"), and Bears Merger Sub, Inc., a Delaware corporation (the "Merger Sub"): (a) the Merger Sub merged with and into Old RTI, with Old RTI surviving as a wholly-owned subsidiary of the Issuer (the "Merger"); (b) the Member contributed all of the issued and outstanding membership interests of Paradigm Spine, LLC, a Delaware limited liability company and wholly owned subsidiary of the Member, to the Issuer; and (c) the Issuer was renamed "RTI Surgical Holdings, Inc." F2: Pursuant to the Master Transaction Agreement, at the effective time of the Merger: (a) each issued and outstanding share of common stock of Old RTI converted automatically into one share of the Issuer's common stock; (b) each issued and outstanding share of Series A Convertible Preferred Stock of Old RTI converted automatically into one share of the Issuer's Series A Convertible Preferred Stock; and (c) each stock option and restricted stock award granted by Old RTI converted into a stock option or restricted stock award, as applicable, of the Issuer with respect to an equivalent number of shares of the Issuer's common stock on the same terms and conditions as were applicable prior to the Closing. This report reflects the beneficial ownership of the reporting person at the time of the consummation of the Merger and does not include the securities of the Issuer acquired by the reporting person upon the consummation of the Merger. F3: The reporting person will file a Form 4 reflecting his acquisition of the Issuer's securities in connection with the consummation of the Mergers. F4: Total includes 21,322 shares of restricted stock that will vest on 2/26/2020. |
Filing footnotes · ownership attribution and instrument terms
F1: On March 8, 2019, pursuant to the Master Transaction Agreement, by and among the Issuer, RTI Surgical, Inc., a Delaware corporation ("Old RTI"), PS Spine Holdco, LLC, a Delaware limited liability company (the "Member"), and Bears Merger Sub, Inc., a Delaware corporation (the "Merger Sub"): (a) the Merger Sub merged with and into Old RTI, with Old RTI surviving as a wholly-owned subsidiary of the Issuer (the "Merger"); (b) the Member contributed all of the issued and outstanding membership interests of Paradigm Spine, LLC, a Delaware limited liability company and wholly owned subsidiary of the Member, to the Issuer; and (c) the Issuer was renamed "RTI Surgical Holdings, Inc."
F2: Pursuant to the Master Transaction Agreement, at the effective time of the Merger: (a) each issued and outstanding share of common stock of Old RTI converted automatically into one share of the Issuer's common stock; (b) each issued and outstanding share of Series A Convertible Preferred Stock of Old RTI converted automatically into one share of the Issuer's Series A Convertible Preferred Stock; and (c) each stock option and restricted stock award granted by Old RTI converted into a stock option or restricted stock award, as applicable, of the Issuer with respect to an equivalent number of shares of the Issuer's common stock on the same terms and conditions as were applicable prior to the Closing. This report reflects the beneficial ownership of the reporting person at the time of the consummation of the Merger and does not include the securities of the Issuer acquired by the reporting person upon the consummation of the Merger.
F3: The reporting person will file a Form 4 reflecting his acquisition of the Issuer's securities in connection with the consummation of the Mergers.
F4: Total includes 21,322 shares of restricted stock that will vest on 2/26/2020.
Roka BioScience, Inc.
Report date June 28, 2017 · Filed June 30, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.55 · Expires 2027-06-27 | Direct | 3,000 |
Reported balance
After 2017-06-28 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2017-06-28 · Grant · Acquired 3,000 · Balance 3,000 |
SURGALIGN HOLDINGS, INC.
Report date August 15, 2022 · Filed August 17, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 30,809 |
Reported balance
After 2022-08-15 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2022-08-15 · Grant · Acquired 22,857 · Balance 30,809 F1: Represents shares of restricted stock of Surgalign Holdings, Inc. (the "Company") granted as part of the director compensation program of the Company, all of which will vest on the first anniversary of the date of grant. F2: The total shares reported reflect 1:30 reverse stock split on May 17, 2022. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of restricted stock of Surgalign Holdings, Inc. (the "Company") granted as part of the director compensation program of the Company, all of which will vest on the first anniversary of the date of grant.
F2: The total shares reported reflect 1:30 reverse stock split on May 17, 2022.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 27, 2004 Filed Apr 28, 2004 19:02 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionCommon | 4,400 | $13.41 | $59,004.00 |
DisclosureSEC source: 0000200406-04-000075 · edgar.xml · nonDerivative · entry 1 VALERIANI NICHOLAS J · CIK 0001263149 · Vice President,Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,595 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Adjusted to reflect two-for-one stock splits in 1996 and 2001. Read SEC document |
| March 31, 2004 Filed Apr 28, 2004 19:02 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | OtherCommon | 206 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000200406-04-000075 · edgar.xml · nonDerivative · entry 3 VALERIANI NICHOLAS J · CIK 0001263149 · Vice President,Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,398 F2 · price: Shares acquired under Johnson & Johnson's 401(k) and ESOP Savings Plans at Plans' most recent reporting date (03/31/2004). Read SEC document |
| February 09, 2004 Filed Feb 11, 2004 18:31 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantEmployee Stock Option (Right to Buy) · Derivative | 70,000 | Not disclosed Strike: $53.93 | Not disclosed |
DisclosureSEC source: 0000200406-04-000031 · edgar.xml · derivative · entry 5 VALERIANI NICHOLAS J · CIK 0001263149 · Vice President,Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Common · 70,000 shares Expires 2014-02-07 F4 · security: Awarded under Issuer's Stock Option Plan. F4 · price: Awarded under Issuer's Stock Option Plan. Read SEC document |
| February 09, 2004 Filed Feb 11, 2004 18:31 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantCommon | 1,022 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000200406-04-000031 · edgar.xml · nonDerivative · entry 1 VALERIANI NICHOLAS J · CIK 0001263149 · Vice President,Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,195 F1 · price: Awarded under Issuer's Stock Compensation Plan. Read SEC document |
| January 30, 2004 Filed Feb 11, 2004 18:31 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | OtherCommon | 115 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000200406-04-000031 · edgar.xml · nonDerivative · entry 2 VALERIANI NICHOLAS J · CIK 0001263149 · Vice President,Human Resources 10b5-1 filing: Not disclosed Ownership: Indirect · 401 (k) and ESOP Savings Plans Disclosed balance after: 7,192 F2 · price: Shares acquired under Johnson & Johnson's 401(k) and ESOP Savings Plans at Plans' most recent reporting date (01/30/2004). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.